new
   Indications for Deflazacort (Calcort)
502
Oct 17, 2025

Deflazacort (Calcort) is a glucocorticoid drug mainly used to treat a variety of inflammatory and autoimmune diseases.

Indications for Deflazacort (Calcort)

Duchenne Muscular Dystrophy (DMD)

Deflazacort has been approved by the FDA for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged 5 years and older, which is the primary indication of this drug.

Clinical studies have shown that deflazacort can delay the degeneration of muscle function in DMD patients, improve motor function, and prolong the duration of maintaining walking ability.

Inflammatory and Autoimmune Diseases

Deflazacort can also be used to treat a variety of inflammatory and autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, severe asthma, and allergic diseases.

Its anti-inflammatory effect is approximately 70% that of prednisone, but it has relatively fewer side effects.

Specifications and Properties of Deflazacort (Calcort)

Oral Suspension

The specification of the newly approved deflazacort oral suspension is 22.75mg/mL.

This suspension is a combination product, consisting of the drug and device components.

Tablets

Common specifications of deflazacort tablets include 6mg, 18mg, and 30mg. The tablets are generally white or off-white, and their specific properties may vary slightly among different manufacturers.

The tablets should be swallowed whole and should not be split or crushed.

Storage and Usage of Deflazacort (Calcort)

Storage Conditions

Both deflazacort oral suspension and tablets should be stored at room temperature (20-25°C), with short-term storage allowed in an environment of 15-30°C.

It is important to keep the drug out of the reach of children and avoid direct sunlight and humid environments.

The suspension should remain in intact packaging before opening; after opening, it should be stored in accordance with the requirements in the instruction manual.

Oral Suspension

It should be shaken thoroughly before use.

A dedicated dosing device should be used to measure the dose accurately.

It can be mixed with a small amount of water or fruit juice for administration to improve taste.

After opening, it must be used up within the specified time.

Tablets

It is recommended to take the tablets after breakfast in the morning to conform to the body's cortisol secretion rhythm.

The tablets should be swallowed whole and should not be chewed or crushed.

Patients taking the drug for a long time should not discontinue it suddenly; the dose needs to be reduced gradually.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Indications for Odevixibat (Bylvay)

Odevixibat (Bylvay) is an ileal bile acid transporter (IBAT) inhibitor, mainly indicated for the treatment of...

Friday, October 24th, 2025, 13:40
How to Use Pramipexole

Pramipexole is a non-ergot dopamine receptor agonist, mainly used for the treatment of Parkinson's disease (PD)...

Friday, October 24th, 2025, 13:37
Indications of Pomalidomide

Pomalidomide is a thalidomide analog developed by Bristol-Myers Squibb.

Indications of...

Friday, October 24th, 2025, 13:34
How to Purchase Pramipexole

Pramipexole is a non-ergot dopamine receptor agonist, primarily indicated for the treatment of Parkinson's...

Friday, October 24th, 2025, 13:31
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved